Speaker: Wakenda K. Tyler, MD MPH FAAOS, Moderator, Make Pigmented Villonodular Synovitis a Thing of the Past!
Wakenda K. Tyler, MD MPH FAAOS: Hello, my name is Wakanda Tyler, and I am an orthopaedic surgical oncologist at Columbia University Medical Center and the Division Chief of Orthopaedic Oncology here.
Wakenda K. Tyler, MD MPH FAAOS: We're planning on doing a case based presentation style so that we can have cases and then intertwine some educational components to those cases. And I'm hoping that there will be a good amount of kind of audience participation and discussion involved in both the case presentation and the learning components.
Wakenda K. Tyler, MD MPH FAAOS: I would definitely recommend attending this session for anybody who takes care of patients both in general orthopaedics, sports medicine or oncology. Giant cell tumor of tendon sheath, particularly the diffuse form, is really one of those disease entities that most of us bang our heads against the table when it comes into our office or against the computer. Because we know how complicated and frustrating it can be. And I'm hoping that this session provides people with some tools for, when it's appropriate to do surgical intervention, when it's appropriate to think about the next step from a medical intervention process and how to counsel patients on what's right for them. So I'm really hoping this will make your lives easier in the future when these patients come through the door. And almost all of us in many different aspects of orthopaedics are going to see this.
Wakenda K. Tyler, MD MPH FAAOS: So I think the actionable takeaways from our session will be, you know, the basics of understanding when surgery is appropriate for this disease entity, when it's appropriate to refer for medical management and the basics on counseling patients on what might be right for them in various situations.
Wakenda K. Tyler, MD MPH FAAOS: I think that this particular session is going to be very relevant to anybody who does sports medicine, anybody that does orthopaedic oncology and anybody who's a general orthopaedic surgeon. Because almost all of those fields are going to see, giant cell tumor of tendon sheath in one form or another in their practices and knowing when to treat, how to treat when it is treated surgically, and then when to refer when it needs medical management. It's going to be important for pretty much everybody in our field to have a good understanding of.
Wakenda K. Tyler, MD MPH FAAOS: I'm really looking forward to seeing people at this session, I hope it's one that people can enjoy and get some educational components from.